Nuromark Injection
By Nuromark
Rx
2ml Injection in a Vial

Composition
Nicotinamide(100mg) + Vitamin B6 (Pyridoxine)(100mg) + Vitamin B2(5mg) + Thiamine(Vitamin B1)(100mg) + Methylcobalamin(1000mcg)

Manufacturer - Unimarck Healthcare Ltd
128, HPSIDC . Inds. Area , baddi -173205(H.P)

Expires on or after
June, 2026

liver
Nuromark Injection is considered safe for individuals with liver disease. Based on the available data, it appears that adjusting the dosage of Nuromark Injection may not be necessary for patients with liver issues. However, it is always recommended to consult your doctor before using this medication to ensure it is safe and appropriate for your specific situation.

kidney
Nuromark Injection is likely safe for use in patients with kidney disease. Current data indicates that adjusting the dose of Nuromark Injection may not be necessary for these patients. It is recommended to seek advice from your doctor.

alcohol
When using Nuromark Injection, caution should be taken when consuming alcohol. It is recommended to consult your doctor regarding alcohol consumption while using this medication.

driving
When using Nuromark Injection, it is typically safe to drive as it does not usually impact your driving ability. However, always use caution and assess your own reaction time and focus before driving to ensure safety.

pregnancy
Information on the safety of using Nuromark Injection during pregnancy is currently unavailable. It is advisable to consult your doctor if you are pregnant and considering using this medication.

breastfeeding
Nuromark Injection is considered safe for breastfeeding mothers. Research indicates that the medication does not transfer into breastmilk in a concerning level, posing no harm to the infant.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | - |
| Action Class | - |
₹19.58
₹21.75
9.98% OFF
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025
